AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] MKS Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary

Unusual Machines, Inc. (NYSE American: UMAC) filed an 8-K dated June 30, 2025 to disclose two reportable events:

  • Item 3.02 â€� Unregistered Sales of Equity Securities: The equity awards described in Item 5.02 were issued to accredited recipients and relied on the Section 4(a)(2) private-placement exemption.
  • Item 5.02 â€� Compensatory Arrangements of Certain Officers: On June 30, 2025 the Compensation Committee granted fully vested equity bonuses under the 2022 Equity Incentive Plan totalling 325,000 shares/units to senior executives:
    • CEO Dr. Allan Evans: 175,000 restricted common shares issued to an entity he controls.
    • CFO Brian Hoff: 75,000 restricted stock units (RSUs).
    • COO Andrew Camden: 75,000 RSUs.
    The common shares underlying the RSUs are scheduled for delivery in August 2025.

These awards are immediately vested; therefore, the 175,000 shares increase outstanding common stock upon issuance, while delivery of 150,000 additional shares is deferred. No cash consideration was involved.

The filing contains no financial statements, earnings data, or discussion of performance metrics beyond noting that the grants were awarded "for their performance."

Unusual Machines, Inc. (NYSE American: UMAC) ha presentato un modulo 8-K datato 30 giugno 2025 per comunicare due eventi rilevanti:

  • Voce 3.02 â€� Vendite non registrate di titoli azionari: Le azioni azionarie descritte alla Voce 5.02 sono state emesse a destinatari accreditati, avvalendosi dell'esenzione per collocamento privato ai sensi della Sezione 4(a)(2).
  • Voce 5.02 â€� Accordi compensativi di alcuni dirigenti: Il 30 giugno 2025 il Comitato per la Compensazione ha concesso bonus azionari completamente maturati ai sensi del Piano Incentivi Azionari 2022, per un totale di 325.000 azioni/unità a dirigenti senior:
    • CEO Dr. Allan Evans: 175.000 azioni ordinarie vincolate emesse a un'entità da lui controllata.
    • CFO Brian Hoff: 75.000 unità azionarie vincolate (RSU).
    • COO Andrew Camden: 75.000 RSU.
    Le azioni ordinarie sottostanti alle RSU sono previste per la consegna ad agosto 2025.

Questi premi sono immediatamente maturati; pertanto, le 175.000 azioni aumentano il capitale sociale in circolazione al momento dell'emissione, mentre la consegna di ulteriori 150.000 azioni è differita. Non è stata coinvolta alcuna controparte in denaro.

Il documento non contiene bilanci, dati sugli utili o discussioni sulle metriche di performance, se non la semplice indicazione che le assegnazioni sono state concesse "per il loro rendimento."

Unusual Machines, Inc. (NYSE American: UMAC) presentó un formulario 8-K con fecha 30 de junio de 2025 para divulgar dos eventos reportables:

  • Artículo 3.02 â€� Ventas no registradas de valores de capital: Las concesiones de acciones descritas en el Artículo 5.02 se emitieron a destinatarios acreditados y se basaron en la exención de colocación privada de la Sección 4(a)(2).
  • Artículo 5.02 â€� Acuerdos compensatorios de ciertos ejecutivos: El 30 de junio de 2025, el Comité de Compensación otorgó bonos de acciones totalmente adquiridos bajo el Plan de Incentivos de Acciones 2022 por un total de 325,000 acciones/unidades a ejecutivos senior:
    • CEO Dr. Allan Evans: 175,000 acciones comunes restringidas emitidas a una entidad que controla.
    • CFO Brian Hoff: 75,000 unidades de acciones restringidas (RSU).
    • COO Andrew Camden: 75,000 RSU.
    Las acciones comunes subyacentes a las RSU están programadas para su entrega en agosto de 2025.

Estos premios están completamente adquiridos de inmediato; por lo tanto, las 175,000 acciones aumentan las acciones comunes en circulación al momento de la emisión, mientras que la entrega de 150,000 acciones adicionales se difiere. No hubo consideración en efectivo.

La presentación no contiene estados financieros, datos de ganancias ni discusión de métricas de desempeño más allá de señalar que las concesiones se otorgaron "por su desempeño."

Unusual Machines, Inc. (NYSE American: UMAC)ëŠ� 2025ë…� 6ì›� 30ì¼ìž 8-K 보고서를 제출했습니다 ë‘� 가지 ë³´ê³  대ìƒ� 사건ì� 공개하기 위해:

  • 항목 3.02 â€� 등ë¡ë˜ì§€ ì•Šì€ ì£¼ì‹ íŒë§¤: 항목 5.02ì—� 설명ë� ì£¼ì‹ ë³´ìƒì€ ê³µì¸ ìˆ˜ë ¹ì¸ì—ê²� 발행ë˜ì—ˆìœ¼ë©°, 섹션 4(a)(2) 사모 배치 ë©´ì œë¥� 근거ë¡� 하였습니ë‹�.
  • 항목 5.02 â€� 특정 ìž„ì›ì� ë³´ìƒ ê³„ì•½: 2025ë…� 6ì›� 30ì� ë³´ìƒ ìœ„ì›íšŒëŠ” 2022ë…� ì£¼ì‹ ì¸ì„¼í‹°ë¸Œ 계íšì—� ë”°ë¼ ì™„ì „ ì·¨ë“ë� ì£¼ì‹ ë³´ë„ˆìŠ� ì´� 325,000ì£�/단위ë¥� 고위 ìž„ì›ë“¤ì—ê²� 부여했습니ë‹�:
    • CEO Dr. Allan Evans: 그가 통제하는 법ì¸ì—� 발행ë� 175,000 제한 보통ì£�.
    • CFO Brian Hoff: 75,000 제한 ì£¼ì‹ ë‹¨ìœ„(RSU).
    • COO Andrew Camden: 75,000 RSU.
    RSUì—� 기반í•� 보통주는 2025ë…� 8ì›”ì— ì¸ë„ë� 예정입니ë‹�.

ì� ë³´ìƒë“¤ì€ 즉시 완전 ì·¨ë“ë˜ë¯€ë¡�, 175,000주는 발행 ì‹� 유통 보통ì£� 수를 ì¦ê°€ì‹œí‚¤ë©�, 추가 150,000ì£¼ì˜ ì¸ë„ëŠ� 연기ë©ë‹ˆë‹�. 현금 대가ëŠ� í¬í•¨ë˜ì§€ 않았습니ë‹�.

ì� 제출 서류ì—는 재무제표, ìˆ˜ìµ ë°ì´í„�, 성과 ì§€í‘œì— ëŒ€í•� ë…¼ì˜ëŠ� í¬í•¨ë˜ì–´ 있지 않으ë©�, 단지 "성과ì—� 따른 ë³´ìƒ"ìž„ì„ ëª…ì‹œí•˜ê³  있습니다.

Unusual Machines, Inc. (NYSE American : UMAC) a déposé un formulaire 8-K daté du 30 juin 2025 pour divulguer deux événements déclarables :

  • Point 3.02 â€� Ventes non enregistrées de titres de capital : Les attributions d’actions décrites au point 5.02 ont été émises à des bénéficiaires accrédités en s’appuyant sur l’exemption de placement privé prévue à la section 4(a)(2).
  • Point 5.02 â€� Dispositions compensatoires de certains dirigeants : Le 30 juin 2025, le comité de rémunération a accordé des primes d’actions entièrement acquises dans le cadre du Plan d’incitation en actions 2022, totalisant 325 000 actions/unités à des cadres supérieurs :
    • PDG Dr Allan Evans : 175 000 actions ordinaires restreintes émises à une entité qu’il contrôle.
    • Directeur financier Brian Hoff : 75 000 unités d’actions restreintes (RSU).
    • Directeur des opérations Andrew Camden : 75 000 RSU.
    Les actions ordinaires sous-jacentes aux RSU doivent être livrées en août 2025.

Ces attributions sont immédiatement acquises ; par conséquent, les 175 000 actions augmentent le capital social en circulation dès leur émission, tandis que la livraison de 150 000 actions supplémentaires est différée. Aucune contrepartie en espèces n’a été impliquée.

Le dépôt ne contient aucun état financier, données de résultats ou discussion sur les indicateurs de performance, hormis la mention que les attributions ont été accordées « pour leur performance ».

Unusual Machines, Inc. (NYSE American: UMAC) reichte am 30. Juni 2025 ein 8-K-Formular ein, um zwei meldepflichtige Ereignisse offenzulegen:

  • Punkt 3.02 â€� Nicht registrierte Verkäufe von Eigenkapitalwerten: Die in Punkt 5.02 beschriebenen Aktienzuteilungen wurden an akkreditierte Empfänger ausgegeben und beruhten auf der privaten Platzierungsausnahme gemäß Abschnitt 4(a)(2).
  • Punkt 5.02 â€� Vergütungsvereinbarungen bestimmter Führungskräfte: Am 30. Juni 2025 gewährte das Vergütungskomitee vollständig unverfallbare Aktienboni im Rahmen des Equity Incentive Plans 2022 in Höhe von insgesamt 325.000 Aktien/Einheiten an leitende Führungskräfte:
    • CEO Dr. Allan Evans: 175.000 eingeschränkte Stammaktien, ausgegeben an eine von ihm kontrollierte Einheit.
    • CFO Brian Hoff: 75.000 Restricted Stock Units (RSUs).
    • COO Andrew Camden: 75.000 RSUs.
    Die den RSUs zugrunde liegenden Stammaktien sollen im August 2025 geliefert werden.

Diese Zuwendungen sind sofort unverfallbar; somit erhöhen die 175.000 Aktien bei Ausgabe das ausstehende Stammaktienkapital, während die Lieferung von weiteren 150.000 Aktien aufgeschoben wird. Es war keine Barzahlung beteiligt.

Die Einreichung enthält keine Finanzberichte, Gewinnzahlen oder Diskussionen zu Leistungskennzahlen, abgesehen von der Angabe, dass die Zuteilungen "für ihre Leistung" vergeben wurden.

Positive
  • None.
Negative
  • Immediate and pending issuance of 325,000 shares/units creates incremental share dilution without accompanying financial performance disclosure.

Insights

TL;DR—Vested stock awards reward executives but introduce incremental dilution; governance impact appears routine.

The committee’s decision to grant 325 K vested equity units is standard compensation practice and aligns with the company’s 2022 equity plan. Because the CEO’s shares were issued immediately, outstanding share count climbs at once; the RSUs will follow in Aug-2025. The filing does not detail performance metrics or shareholder approval requirements, so transparency on pay-for-performance linkage is limited. Overall, this is a routine incentive action with modest dilution and no strategic shift; I view investor impact as neutral.

TL;DR—Equity bonuses add 0.3 M shares; minor dilution risk, no change to fundamentals.

Assuming Unusual Machines has a multi-million-share float (exact figure not provided), issuance of 325,000 shares/units likely represents a low-single-digit percentage increase. No cash outlay means cash reserves stay intact, but share-based compensation pressures EPS once shares vest/settle. Absence of financial guidance or operational updates limits immediate valuation impact. The transaction is therefore modestly dilutive yet fundamentally immaterial.

Unusual Machines, Inc. (NYSE American: UMAC) ha presentato un modulo 8-K datato 30 giugno 2025 per comunicare due eventi rilevanti:

  • Voce 3.02 â€� Vendite non registrate di titoli azionari: Le azioni azionarie descritte alla Voce 5.02 sono state emesse a destinatari accreditati, avvalendosi dell'esenzione per collocamento privato ai sensi della Sezione 4(a)(2).
  • Voce 5.02 â€� Accordi compensativi di alcuni dirigenti: Il 30 giugno 2025 il Comitato per la Compensazione ha concesso bonus azionari completamente maturati ai sensi del Piano Incentivi Azionari 2022, per un totale di 325.000 azioni/unità a dirigenti senior:
    • CEO Dr. Allan Evans: 175.000 azioni ordinarie vincolate emesse a un'entità da lui controllata.
    • CFO Brian Hoff: 75.000 unità azionarie vincolate (RSU).
    • COO Andrew Camden: 75.000 RSU.
    Le azioni ordinarie sottostanti alle RSU sono previste per la consegna ad agosto 2025.

Questi premi sono immediatamente maturati; pertanto, le 175.000 azioni aumentano il capitale sociale in circolazione al momento dell'emissione, mentre la consegna di ulteriori 150.000 azioni è differita. Non è stata coinvolta alcuna controparte in denaro.

Il documento non contiene bilanci, dati sugli utili o discussioni sulle metriche di performance, se non la semplice indicazione che le assegnazioni sono state concesse "per il loro rendimento."

Unusual Machines, Inc. (NYSE American: UMAC) presentó un formulario 8-K con fecha 30 de junio de 2025 para divulgar dos eventos reportables:

  • Artículo 3.02 â€� Ventas no registradas de valores de capital: Las concesiones de acciones descritas en el Artículo 5.02 se emitieron a destinatarios acreditados y se basaron en la exención de colocación privada de la Sección 4(a)(2).
  • Artículo 5.02 â€� Acuerdos compensatorios de ciertos ejecutivos: El 30 de junio de 2025, el Comité de Compensación otorgó bonos de acciones totalmente adquiridos bajo el Plan de Incentivos de Acciones 2022 por un total de 325,000 acciones/unidades a ejecutivos senior:
    • CEO Dr. Allan Evans: 175,000 acciones comunes restringidas emitidas a una entidad que controla.
    • CFO Brian Hoff: 75,000 unidades de acciones restringidas (RSU).
    • COO Andrew Camden: 75,000 RSU.
    Las acciones comunes subyacentes a las RSU están programadas para su entrega en agosto de 2025.

Estos premios están completamente adquiridos de inmediato; por lo tanto, las 175,000 acciones aumentan las acciones comunes en circulación al momento de la emisión, mientras que la entrega de 150,000 acciones adicionales se difiere. No hubo consideración en efectivo.

La presentación no contiene estados financieros, datos de ganancias ni discusión de métricas de desempeño más allá de señalar que las concesiones se otorgaron "por su desempeño."

Unusual Machines, Inc. (NYSE American: UMAC)ëŠ� 2025ë…� 6ì›� 30ì¼ìž 8-K 보고서를 제출했습니다 ë‘� 가지 ë³´ê³  대ìƒ� 사건ì� 공개하기 위해:

  • 항목 3.02 â€� 등ë¡ë˜ì§€ ì•Šì€ ì£¼ì‹ íŒë§¤: 항목 5.02ì—� 설명ë� ì£¼ì‹ ë³´ìƒì€ ê³µì¸ ìˆ˜ë ¹ì¸ì—ê²� 발행ë˜ì—ˆìœ¼ë©°, 섹션 4(a)(2) 사모 배치 ë©´ì œë¥� 근거ë¡� 하였습니ë‹�.
  • 항목 5.02 â€� 특정 ìž„ì›ì� ë³´ìƒ ê³„ì•½: 2025ë…� 6ì›� 30ì� ë³´ìƒ ìœ„ì›íšŒëŠ” 2022ë…� ì£¼ì‹ ì¸ì„¼í‹°ë¸Œ 계íšì—� ë”°ë¼ ì™„ì „ ì·¨ë“ë� ì£¼ì‹ ë³´ë„ˆìŠ� ì´� 325,000ì£�/단위ë¥� 고위 ìž„ì›ë“¤ì—ê²� 부여했습니ë‹�:
    • CEO Dr. Allan Evans: 그가 통제하는 법ì¸ì—� 발행ë� 175,000 제한 보통ì£�.
    • CFO Brian Hoff: 75,000 제한 ì£¼ì‹ ë‹¨ìœ„(RSU).
    • COO Andrew Camden: 75,000 RSU.
    RSUì—� 기반í•� 보통주는 2025ë…� 8ì›”ì— ì¸ë„ë� 예정입니ë‹�.

ì� ë³´ìƒë“¤ì€ 즉시 완전 ì·¨ë“ë˜ë¯€ë¡�, 175,000주는 발행 ì‹� 유통 보통ì£� 수를 ì¦ê°€ì‹œí‚¤ë©�, 추가 150,000ì£¼ì˜ ì¸ë„ëŠ� 연기ë©ë‹ˆë‹�. 현금 대가ëŠ� í¬í•¨ë˜ì§€ 않았습니ë‹�.

ì� 제출 서류ì—는 재무제표, ìˆ˜ìµ ë°ì´í„�, 성과 ì§€í‘œì— ëŒ€í•� ë…¼ì˜ëŠ� í¬í•¨ë˜ì–´ 있지 않으ë©�, 단지 "성과ì—� 따른 ë³´ìƒ"ìž„ì„ ëª…ì‹œí•˜ê³  있습니다.

Unusual Machines, Inc. (NYSE American : UMAC) a déposé un formulaire 8-K daté du 30 juin 2025 pour divulguer deux événements déclarables :

  • Point 3.02 â€� Ventes non enregistrées de titres de capital : Les attributions d’actions décrites au point 5.02 ont été émises à des bénéficiaires accrédités en s’appuyant sur l’exemption de placement privé prévue à la section 4(a)(2).
  • Point 5.02 â€� Dispositions compensatoires de certains dirigeants : Le 30 juin 2025, le comité de rémunération a accordé des primes d’actions entièrement acquises dans le cadre du Plan d’incitation en actions 2022, totalisant 325 000 actions/unités à des cadres supérieurs :
    • PDG Dr Allan Evans : 175 000 actions ordinaires restreintes émises à une entité qu’il contrôle.
    • Directeur financier Brian Hoff : 75 000 unités d’actions restreintes (RSU).
    • Directeur des opérations Andrew Camden : 75 000 RSU.
    Les actions ordinaires sous-jacentes aux RSU doivent être livrées en août 2025.

Ces attributions sont immédiatement acquises ; par conséquent, les 175 000 actions augmentent le capital social en circulation dès leur émission, tandis que la livraison de 150 000 actions supplémentaires est différée. Aucune contrepartie en espèces n’a été impliquée.

Le dépôt ne contient aucun état financier, données de résultats ou discussion sur les indicateurs de performance, hormis la mention que les attributions ont été accordées « pour leur performance ».

Unusual Machines, Inc. (NYSE American: UMAC) reichte am 30. Juni 2025 ein 8-K-Formular ein, um zwei meldepflichtige Ereignisse offenzulegen:

  • Punkt 3.02 â€� Nicht registrierte Verkäufe von Eigenkapitalwerten: Die in Punkt 5.02 beschriebenen Aktienzuteilungen wurden an akkreditierte Empfänger ausgegeben und beruhten auf der privaten Platzierungsausnahme gemäß Abschnitt 4(a)(2).
  • Punkt 5.02 â€� Vergütungsvereinbarungen bestimmter Führungskräfte: Am 30. Juni 2025 gewährte das Vergütungskomitee vollständig unverfallbare Aktienboni im Rahmen des Equity Incentive Plans 2022 in Höhe von insgesamt 325.000 Aktien/Einheiten an leitende Führungskräfte:
    • CEO Dr. Allan Evans: 175.000 eingeschränkte Stammaktien, ausgegeben an eine von ihm kontrollierte Einheit.
    • CFO Brian Hoff: 75.000 Restricted Stock Units (RSUs).
    • COO Andrew Camden: 75.000 RSUs.
    Die den RSUs zugrunde liegenden Stammaktien sollen im August 2025 geliefert werden.

Diese Zuwendungen sind sofort unverfallbar; somit erhöhen die 175.000 Aktien bei Ausgabe das ausstehende Stammaktienkapital, während die Lieferung von weiteren 150.000 Aktien aufgeschoben wird. Es war keine Barzahlung beteiligt.

Die Einreichung enthält keine Finanzberichte, Gewinnzahlen oder Diskussionen zu Leistungskennzahlen, abgesehen von der Angabe, dass die Zuteilungen "für ihre Leistung" vergeben wurden.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Henry David Philip

(Last) (First) (Middle)
C/O MKS INC.
2 TECH DRIVE

(Street)
ANDOVER MA 01810

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MKS INC [ MKSI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Operations & Corp Mktg
3. Date of Earliest Transaction (Month/Day/Year)
07/03/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 07/03/2025 S(1) 2,000 D $105 20,571.18 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 12, 2025.
/s/ James Kruger, attorney-in-fact 07/07/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Unusual Machines (UMAC) disclose in its June 30 2025 Form 8-K?

The company reported unregistered equity awards totaling 325,000 shares/units granted to its CEO, CFO, and COO.

How many shares did CEO Dr. Allan Evans receive?

Dr. Evans was issued 175,000 fully-vested restricted common shares through an entity he controls.

When will the RSUs granted to the CFO and COO be delivered?

The 150,000 RSUs granted to Brian Hoff and Andrew Camden are scheduled to settle in August 2025.

Were the equity awards registered with the SEC?

No. They were issued under the Section 4(a)(2) private-placement exemption and are therefore unregistered.

Does the 8-K include any financial or earnings information?

No financial statements, revenue, or earnings metrics were provided in this filing.
MKS Inc.

NASDAQ:MKSI

MKSI Rankings

MKSI Latest News

MKSI Latest SEC Filings

MKSI Stock Data

7.02B
66.64M
0.6%
107.92%
4.7%
Scientific & Technical Instruments
Industrial Instruments for Measurement, Display, and Control
United States
ANDOVER